Is Dexmedetomidine an Ideal Sedative Agent for Neurosurgical Patients?

Tan J.A. , Ho K.M. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010; 36: 926–939.

Ho K.M. , Ng J.Y. The use of propofol for medium and long-term sedation in critically ill adult patients: a meta-analysis. Intensive Care Med 2008; 34: 1969–1979.

Tan J.A. , Ho K.M. Use of remifentanil as a sedative agent in critically ill adult patients: a meta-analysis. Anaesthesia 2009; 64: 1342–1352.

James M.L. , Olson D.M. , Graffagnino C.G. A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth Intensive Care 2012; 40: 949–957.

Venn R.M. , Karol M.D. , Grounds R.M. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002; 88: 669–675.

Hiraoka H. , Yamamoto K. , Miyoshi S. , Morita T. , Nakamura K. , Kadoi Y. Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain. Br J Clin Pharmacol 2005; 60: 176–182.

Paris A. , Tonner P.H. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005; 18: 412–418.

Venn R.M. , Hell J. , Grounds R.M. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4: 302–308.

Venn R.M. , Bradshaw C.J. , Spencer R. , Brealey D. , Caudwell E. , Naughton C. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136–1142.

Huupponen E. , Maksimow A. , Lapinlampi P. , Särkelä M. , Saastamoinen A. , Snapir A. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand 2008; 52: 289–294.

Augustes R. , Ho K.M. Meta-analysis of randomised controlled trials on daily sedation interruption for critically ill adult patients. Anaesth Intensive Care 2011; 39: 401–409.

Schoeler M. , Loetscher P.D. , Rossaint R. , Fahlenkamp A.V. , Eberhardt G. , Rex S. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol 2012; 12: 20.

Sanders R.D. , Sun P. , Patel S. , Li M. , Maze M. , Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol Scand 2010; 54: 710–716.

Sato K. , Kimura T. , Nishikawa T. , Tobe Y. , Masaki Y. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand 2010; 54: 377–382.

Goyagi T. , Nishikawa T. , Tobe Y. , Masaki Y. The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats. Acta Anaesthesiol Scand 2009; 53: 1176–1183.

Cosar M. , Eser O. , Fidan H. , Sahin O. , Buyukbas S. , Ela Y. The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage. Surg Neurol 2009; 71: 54–59.

Sulemanji D.S. , Dönmez A. , Aldemir D. , Sezgin A. , Türkoglu S. Dexmedetomidine during coronary artery bypass grafting surgery: is it neuroprotective?—A preliminary study. Acta Anaesthesiol Scand 2007; 51: 1093–1098.

Tobias J.D. Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 2008; 23: 403–408.